Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)

PHASE3RecruitingINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

June 30, 2026

Conditions
Social Anxiety Disorder
Interventions
DRUG

Fasedienol Nasal Spray

Nasal spray delivered 20 minutes before the PSC

DRUG

Placebo Nasal Spray

Nasal spray delivered 20 minutes before the PSC

Trial Locations (24)

10128

RECRUITING

Vistagen Clinical Site, New York

19063

TERMINATED

Vistagen Clinical Site, Media

21208

RECRUITING

Vistagen Clinical Site, Baltimore

32256

TERMINATED

Vistagen Clinical Site, Jacksonville

32801

RECRUITING

Vistagen Clinical Site, Orlando

33407

RECRUITING

Vistagen Clinical Site, West Palm Beach

33803

RECRUITING

Vistagen Clinical Site, Lakeland

38119

RECRUITING

Vistagen Clinical Site, Memphis

60612

RECRUITING

Vistagen Clinical Site, Chicago

63304

RECRUITING

Vistagen Clinical Site, Saint Charles

66210

ACTIVE_NOT_RECRUITING

Vistagen Clinical Site, Overland Park

72211

RECRUITING

Vistagen Clinical Site, Little Rock

72703

RECRUITING

Vistagen Clinical Site, Fayetteville

76104

ACTIVE_NOT_RECRUITING

Vistagen Clinical Site, Fort Worth

80209

RECRUITING

Vistagen Clinical Site, Denver

84020

RECRUITING

Vistagen Clinical Site, Draper

85012

RECRUITING

Vistagen Clinical Site, Phoenix

89119

RECRUITING

Vistagen Clinical Site, Las Vegas

91403

RECRUITING

Vistagen Clinical Site, Sherman Oaks

92056

RECRUITING

Vistagen Clinical Site, Oceanside

94549

RECRUITING

Vistagen Clinical Site, Lafayette

98201

RECRUITING

Vistagen Clinical Site, Everett

06416

RECRUITING

Vistagen Clinical Site, Cromwell

02131

RECRUITING

Vistagen Clinical Site, Boston

All Listed Sponsors
lead

VistaGen Therapeutics, Inc.

INDUSTRY